Cargando…
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
The therapeutic potential of venom-derived drugs is evident today. Currently, several significant drugs are FDA approved for human use that descend directly from animal venom products, with others having undergone, or progressing through, clinical trials. In addition, there is growing awareness of t...
Autores principales: | Coulter-Parkhill, Aimee, McClean, Stephen, Gault, Victor A, Irwin, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491154/ https://www.ncbi.nlm.nih.gov/pubmed/34621137 http://dx.doi.org/10.1177/11795514211006071 |
Ejemplares similares
-
Proglucagon-Derived Peptides as Therapeutics
por: Lafferty, Ryan A., et al.
Publicado: (2021) -
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin
por: Martin, Christine M., et al.
Publicado: (2016) -
Xenin and Related Peptides: Potential Therapeutic Role in Diabetes
and Related Metabolic Disorders
por: Craig, Sarah L, et al.
Publicado: (2021) -
Nanobiotechnology with Therapeutically Relevant Macromolecules from Animal Venoms: Venoms, Toxins, and Antimicrobial Peptides
por: Roque-Borda, Cesar Augusto, et al.
Publicado: (2022) -
Cell-Penetrating Peptides Derived from Animal Venoms and Toxins
por: Rádis-Baptista, Gandhi
Publicado: (2021)